Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
05/17/2007 | US20070110763 Polypeptides of streptococcus pyogenes |
05/17/2007 | US20070110750 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
05/17/2007 | US20070110749 Centrosome proteins and uses thereof |
05/17/2007 | US20070110743 Methods of protein production using anti-senescence compounds |
05/17/2007 | US20070110742 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
05/17/2007 | US20070110733 Compositions and methods for stem cell delivery |
05/17/2007 | US20070110717 Dna vaccines against tumor growth and methods of use thereof |
05/17/2007 | US20070110713 Novel multifunctional cytokines |
05/17/2007 | US20070110686 Peptide-based organic sunscreens |
05/16/2007 | EP1785487A2 Polypeptides involved in the expression of resistance to glycopeptide antibiotics |
05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
05/16/2007 | EP1785485A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress |
05/16/2007 | EP1784503A1 Urine markers for detection of bladder cancer |
05/16/2007 | EP1784424A2 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
05/16/2007 | EP1784212A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
05/16/2007 | EP1487981B1 Growth regulating proteins |
05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
05/16/2007 | EP1263790B1 Monoclonal antibodies to the human ldl receptor, their production and use |
05/16/2007 | EP1245680B1 Gibberellin 2 beta-hydroxylase genes of rice and uses thereof |
05/16/2007 | EP1172436B1 Ceramidase gene |
05/16/2007 | EP1165603B1 Human neurogenin 3-encoding nucleotide sequences |
05/16/2007 | EP1132468B1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
05/16/2007 | EP1127150B1 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
05/16/2007 | EP0920491B1 Immortalized cell lines for virus growth |
05/16/2007 | CN1965085A Mutated prokaryotic cells with high secretion-levels |
05/16/2007 | CN1962873A Expression method of IFN-lambada 1 and its special expression vector and engineering bacterium |
05/16/2007 | CN1962870A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
05/16/2007 | CN1962694A Antibody for detecting chlamydia pneumoniae |
05/16/2007 | CN1961743A 5'-ribonucleotide-rich yeast extract and its production |
05/16/2007 | CN1316028C Expression vector, engineering bacteria of N* deacetylating Alpha 1 monomer of human thymosin, and preparation method |
05/16/2007 | CN1316022C Novel chimeric TNF ligands |
05/16/2007 | CN1316016C Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
05/16/2007 | CN1315537C LIM Mineralization protein splice variants |
05/15/2007 | US7217809 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
05/15/2007 | US7217808 RFRP-3 and DNA thereof |
05/15/2007 | US7217801 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
05/15/2007 | US7217799 Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer |
05/15/2007 | US7217798 has an increased (or decreased) in vivo half-life by virtue of the presence of a modified IgG constant domain (preferably from a human IgG), or FcRn-binding portion thereof (preferably the Fc or hinge-Fc domain) |
05/15/2007 | US7217797 Engineered immunoglobulins for use in immunodiagnostics and/or therapeutics |
05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
05/15/2007 | US7217786 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
05/15/2007 | US7217559 Gene encoding cyclododecanone monooxygenase |
05/15/2007 | US7217552 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule |
05/15/2007 | US7217548 N-acetylglucosaminlytransferase and polynucleotide encoding the same |
05/15/2007 | US7217544 with recombinant microorganism transformed with polynucleotides encoding the enzymes: D-amino acid oxidase; L-amino acid dehydrogenase, and an enzyme that regenerates NADH; overexpression |
05/15/2007 | US7217541 Culuring transgenic cells which codes bactericides; genetic vaccines |
05/15/2007 | US7217540 Polynucleotide encoding IL-1 zeta, TDZ.1 isoform polypeptide |
05/15/2007 | US7217539 Cell death inducers for mast cells |
05/15/2007 | US7217538 Nucleic acid molecule containing a nucleotide sequence encoding CaEss1 (candida albicans) gene or having at least 70% homology; antiproliferative application |
05/15/2007 | US7217535 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
05/15/2007 | US7217514 Generation of variation in preferential nucleotide seuences; obtain nucleotide sequences, incubate with variation mixture, recover variant products |
05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
05/15/2007 | CA2515166C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
05/15/2007 | CA2394616C Gene cluster for ramoplanin biosynthesis |
05/15/2007 | CA2332131C Serine protease-specific monoclonal antibody and utilization thereof |
05/15/2007 | CA2324649C Human p51 genes and gene products thereof |
05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
05/15/2007 | CA2198965C Method for culturing microorganisms having methanol metabolic pathway |
05/15/2007 | CA2176948C Chaperonin 10 |
05/15/2007 | CA2165672C Antibodies specific for human prostate glandular kallikrein |
05/15/2007 | CA2156397C Rapamycin assay |
05/15/2007 | CA2130452C Altered antibodies, products and processes relating thereto |
05/15/2007 | CA2089391C Gram-positive alkaliphilic microorganisms |
05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
05/15/2007 | CA2071879C Glutamate receptor compositions and methods |
05/15/2007 | CA2065414C Treatment of autoimmune disease |
05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
05/10/2007 | WO2007053731A2 Expression of soluble factor viii proteins in bacteria |
05/10/2007 | WO2007053655A2 Cell-free synthesis of membrane bound polypeptides |
05/10/2007 | WO2007053577A2 Compositions and methods for diagnosing and treating cancer |
05/10/2007 | WO2006138225B1 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
05/10/2007 | WO2006073976A3 Compositions, methods, and kits for enhancing protein expression, solubility and isolation |
05/10/2007 | WO2006067163A3 Blood pressure lowering oligopeptides in a single enzymatic step |
05/10/2007 | WO2006047242A3 Duffy antigen receptor for chemokines and use thereof |
05/10/2007 | WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease |
05/10/2007 | US20070107085 Process for proteolytic cleavage and purification of recombinant proteins produced in plants |
05/10/2007 | US20070107080 Production of 3-hydropropionic acid using beta-alanine/pyruvate aminotransferase |
05/10/2007 | US20070106070 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell |
05/10/2007 | US20070106069 Non-Human Primate Fc Receptors and Methods of Use |
05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
05/10/2007 | US20070106067 Assay kit and antibody for human low molecular weight cd14 |
05/10/2007 | US20070106065 TAT- 001 and methods of assessing and treating cancer |
05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
05/10/2007 | US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
05/10/2007 | US20070105770 Transglutaminase mediated conjugation of peptides |
05/10/2007 | US20070105767 Modulation of the interaction of muc1 with muc1 ligands |
05/10/2007 | US20070105764 Fusion protein for controlling production of proteins in bioreactor: cellular therapy (somatic gene therapy); antiviral therapies |
05/10/2007 | US20070105762 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
05/10/2007 | US20070105755 One pot desialylation and glycopegylation of therapeutic peptides |
05/10/2007 | US20070105754 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition insecticide use of lectin KM+ to treat cicatrizations, use of lectin KM+ to prepare immunomodulating medicament, use of lectin KM+ to prepare anti-bacterial medicament, use lectin KM+ to prpare anti-viral medicament, use of lectin KM+ to prepare anti-parasite medicament, use of lectin KM+ to prepare anti-fungal medicament, use of lectin KM+ to prepare anti-parasite medicament expression method, DNA vector, recombinant |
05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
05/10/2007 | US20070105219 Retrovirus from the HIV group and its use |
05/10/2007 | US20070105211 Optical fiber array device capable of simultaneously performing multiple functional assays |